NCT07233291: A Pilot Study to Assess How Safe and Effective Oral Roflumilast is for Treating Moderate to Severe Psoriasis in Adults
- State
- Under way
- Phase
- Phase 2
- People
- 36 planned
- Started
- 20 Aug 2025
- Primary completion
- 28 Feb 2026
- Arms
- Oral Roflumilast for Adults with Moderate-to-Severe Psoriasis
- Results
- None posted
- 20 Aug 2025: Trial started
- 18 Nov 2025: Trial registered